The fastest growing healthcare stock in the United States is a micro-cap that will grow your portfolio like it’s on steroids.
Several years ago, Millennium Healthcare (MHCC) modeled their business to align with Obamacare, and now revenues are ready to explode from $1 MILLION PER YEAR to over $200 MILLION PER YEAR.
This explosive growth is being driven by recently announced contracts with over 400 physician offices and by demand from thousands of additional physicians who are standing in line to sign up with Millennium.
Millennium’s state-of-the-art cardiovascular and cancer diagnostics for early detection are FREE TO PATIENTS and FULLY PAID TO THE DOCTOR by Medicare and private insurance companies. The patient pays nothing, yet receives the benefit of the best non-invasive early detection tests available.
With the new Affordable Care Act and complex ICD-10 billing codes, Doctor’s incomes are declining. Millennium HealthCare diagnostics will provide doctors with average additional income of more than $500,000 per year per office.
Millennium’s offering to physicians is so attractive that over 400 offices have already signed up, 1,000 more offices are in legal and ready to be signed and thousands more are lined up to become a Millennium customer. Millennium is now beginning to roll out the diagnostics to their customers.
Millennium has about 70 million shares outstanding and sales contracts that will deliver over $200 million per year. With an industry average price to sales ratio of 6 to 1, Millennium shares could easily be trading over $10 per share in the next 12 months.
And . . . consider that thousands of additional doctors are in now in line to sign with Millennium, and that could make these sizeable numbers appear small.
Millennium shares have been trading between $.60 and $1.50 for the past month and with record contracts and sales about to happen, shares have the potential to increase the value of any stock portfolio dramatically.